Adaptive Biotechnologies (ADPT) Goodwill & Intangibles (2018 - 2026)

Adaptive Biotechnologies has reported Goodwill & Intangibles for 9 years, with the latest figure at $120.3 million in Q1 2026.

• Quarterly Goodwill & Intangibles fell 1.39% year-over-year to $120.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $120.3 million (down 1.39% YoY) and the FY2025 annual result came in at $120.7 million, down 13.35% from the prior year.
• Goodwill & Intangibles was little changed at $120.3 million in Q1 2026 per ADPT's latest filing, from $120.7 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $139.3 million in Q1 2022 and troughed at $120.3 million in Q1 2026.
• A 5-year average of $127.0 million and a median of $124.5 million in 2023 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2023 and 2025: Goodwill & Intangibles climbed 10.73% in 2023, then decreased 13.35% in 2025.
• Over 5 years, Goodwill & Intangibles stood at $125.8 million in 2022, then climbed by 10.73% to $139.3 million in 2023, then changed by 0.0% to $139.3 million in 2024, then fell by 13.35% to $120.7 million in 2025, then decreased by 0.35% to $120.3 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $120.3 million, $120.7 million, and $121.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.